These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8898529)
21. Should pharmacogenomic studies be required for new drug approval? Relling MV; Hoffman JM Clin Pharmacol Ther; 2007 Mar; 81(3):425-8. PubMed ID: 17339872 [TBL] [Abstract][Full Text] [Related]
22. Ethnic differences in reactions to drugs and other xenobiotics outlook of a geneticist. Goedde HW Prog Clin Biol Res; 1986; 214():9-20. PubMed ID: 3460099 [No Abstract] [Full Text] [Related]
24. [Culture and biology in psychopharmacological treatment of ethnic minorities]. Nørregaard C Ugeskr Laeger; 2012 Feb; 174(6):337-40. PubMed ID: 22310004 [TBL] [Abstract][Full Text] [Related]
25. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression. Cacabelos R Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277 [TBL] [Abstract][Full Text] [Related]
26. [Basic problems and tasks of clinical pharmacogenetics]. Skakun NP Klin Med (Mosk); 1980 Jan; 58(1):11-6. PubMed ID: 6988636 [No Abstract] [Full Text] [Related]
27. [Pharmacogenetics and tailored drug treatment in schizophrenia]. Andreassen OA; Steen VM Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555 [TBL] [Abstract][Full Text] [Related]
28. Ethnicity and psychopharmacology. Bridging the gap. Lin KM; Anderson D; Poland RE Psychiatr Clin North Am; 1995 Sep; 18(3):635-47. PubMed ID: 8545272 [TBL] [Abstract][Full Text] [Related]
29. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Bernard S; Neville KA; Nguyen AT; Flockhart DA Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics and therapeutic strategies for dementia. Cacabelos R Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004 [TBL] [Abstract][Full Text] [Related]
31. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. Anderson GD J Womens Health (Larchmt); 2005; 14(1):19-29. PubMed ID: 15692274 [TBL] [Abstract][Full Text] [Related]
32. When genes and drugs collide. Kiser K Minn Med; 2005 Mar; 88(3):22-4, 54. PubMed ID: 15852591 [No Abstract] [Full Text] [Related]
33. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future. Preskorn SH J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276 [TBL] [Abstract][Full Text] [Related]
35. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Murray M J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946 [TBL] [Abstract][Full Text] [Related]
36. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations. Sheppard C; Beyel V; Fracchia J; Merlis S Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114 [TBL] [Abstract][Full Text] [Related]
37. Fundamentals and applications of pharmacogenetics for the clinical laboratory. Linder MW; Valdes R Ann Clin Lab Sci; 1999; 29(2):140-9. PubMed ID: 10219702 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics: a reality or misplaced optimism? Mutsatsa S; Currid TJ J Psychiatr Ment Health Nurs; 2013 Apr; 20(4):314-20. PubMed ID: 22512271 [TBL] [Abstract][Full Text] [Related]